This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako Kyoto

Kiyotoshi Mori
Head of Research Division at Chiome Bioscience Inc.
Speaker

Profile

Kiyotoshi Mori is Head of Research Division at Chiome Bioscience Inc., effective April 2026. He brings nearly 30 years of pharmaceutical R&D experience, spanning drug discovery, translational and nonclinical research, portfolio management, external alliances, and research leadership. Before joining Chiome, he held senior roles at Kyowa Kirin, leading research across antibody biologics, ADCs, bispecific antibodies, small molecules, and emerging modalities such as gene and cell therapies, while also promoting academic collaborations with institutions including La Jolla Institute for Immunology. His expertise covers immunology and oncology, particularly hematological malignancies and cancer immunology, as well as autoimmune and allergic diseases.

Agenda Sessions

  • Advancing Next-Generation Antibody Drug Discovery through Chiome’s DoppeLib Platform and Integrated Drug Discovery Partnerships

    14:45